Table II.
Group | DAO (mg/ml) | Endotoxin (EU/ml) | D-lactic acid (mg/l) |
---|---|---|---|
C | 6.11±0.07 | 0.66±0.018 | 8.73±0.04 |
M | 7.88±1.10a | 0.86±0.05a | 15.46±0.31a |
T | 6.51±0.59b | 0.76±0.01b | 13.47±0.13b |
G | 6.72±0.19b | 0.74±0.02b | 13.86±0.07b |
N | 6.54±0.40b | 0.77±0.004b | 14.20±0.17b |
L | 6.34±1.21b | 0.70±0.01b | 10.43±0.15b |
Data are reported as mean ± SD, n=10.
P<0.01 vs. C group
P<0.01 vs. M group. DAO, diamine oxidase. C, control group; M, ALD group; T, Golden Bifid treatment group; G, Glutamine treatment group; N, Medilac-S® treatment group; L, Golden Bifido and glutamine treatment group.